The assay is designed to detect the N, S and RdRP genes. Credit: Andreas Lischka / Pixabay.

Health Canada has authorised Seegene’s Allplex SARS CoV-2 FluA/FluB/RSV Assay under its Interim Order.

The new multiplex real-time PCR assay is designed to identify the N, S and RdRP genes, which are used to detect SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus (RSV), in a single test.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

It enables the differentiation and amplification of respiratory symptoms simultaneously.

The Allplex SARS-CoV-2/Flu A/Flu B/RSV Assay can be run on the company’s integrated all-in-one automated platform, which enables high-throughput testing.

On 13 January, the company delivered 340,000 Covid-19 test kits to Canada to support the increasing demand for kits in the country.

See Also:

Seegene chief sales and marketing officer Ho Yi said: “Demand for Covid-19 tests is skyrocketing due to the resurgence of confirmed cases.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“We are fully prepared to supply enough test kits globally and will continue to be strong global partners in the effort to manage the spread of Covid-19.”

The company also stated that the latest approval will allow it to increase awareness of its product in countries close to Canada, such as those in Latin America.

In a separate development, Seegene has delivered more than five million Covid-19 test kits to Israel to support detection of the Omicron variant and reduce its spread.

Last December, the company delivered nearly 1.7 million Covid-19 test kits along with associated consumables. An additional 3.4 million tests are planned to be delivered this month.

Seegene will send various products to Israel, including its Allplex SARS CoV-2 FluA/FluB/RSV Assay and Allplex SARS-CoV-2 Master Assay.

Last month, the company confirmed that its Allplex SARS-CoV-2 Master Assay has the ability to detect the new Omicron Covid-19 variant.